ContextCentral venous catheters impregnated with chlorhexidine and silver sulfadiazine
have recently been introduced for the prevention of catheter-related infections. However …

ContextA recent randomized controlled trial and meta-analysis indicated that central venous
catheters impregnated with an antiseptic combination of chlorhexidine and silver …

BACKGROUND: Bloodstream infection related to a central venous catheter is a substantial
clinical and economic problem. To develop policy for managing the risks of these infections …

Background: Bloodstream infection related to short-term use of noncuffed central venous
catheters is a common and serious problem. Technologic innovations to reduce the risk for …

The most promising options for reducing catheter-related blood stream infection are heparin-
coated or antibiotic-impregnated central venous catheters. Large, high-quality randomized …

Background: Central venous catheter–related infections are a significant medical problem.
Improved preventive measures are needed. Objective: To ascertain 1) effectiveness of a …

Central venous catheterization represents a significant medical advancement, particularly in
the treatment of critical ill. However, there is a high risk of central venous catheters-related …

Objective: To test the efficacy of the ARROWgard (Arrow International Inc, Reading, Pa)
central venous catheter (CVC) coated with silver sulfadiazine and chlorhexidine (A-CVC) in …

Controversy surrounds the role of central venous catheters (CVCs) impregnated with
antimicrobial agents in the prevention of catheter-related bloodstream infection (CRBSI). We …

Background The indication of antiseptic-coated catheters remains debated. Objective To test
the ability of the new generation of chlorhexidine-silver and sulfadiazine-coated catheters …